Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.24564 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.24728 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.25131 | 10 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.18192 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.21597 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.30697 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.27013 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.22565 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.21334 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.23651 | 10 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.23305 | 10 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.22009 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.23763 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.23751 | 10 |